Ex parte MAYRAND - Page 7




               Appeal No. 1999-1266                                                                                                
               Application No. 08/859,472                                                                                          


                       What is missing from the examiner's analysis and review of the facts before us, is any                      
               direction or suggestion to be found in the prior art, including Abramson, to select the particular                  
               enzyme required by claim 16, from those described by Abramson, for use in a PCR                                     
               hybridization process as presently claimed.  As pointed out by appellant (Brief, page 6):                           
                       Abramson teaches "DNA polymerases which have been altered or mutated                                        
                       such that a different level of 5' to 3' exonuclease activity is exhibited from that                         
                       which is exhibited by the native enzyme." . . . That is, Abramson teaches DNA                               
                       polymerases which have both attenuated and enhanced 5'->3' exonuclease                                      
                       activity.                                                                                                   
               Taken as a whole, we agree with appellant that "Abramson's teaching is . . . somewhat                               
               ambiguous."  (Brief, page 6).  However, in the only situation where Abramson addresses                              
               which enzyme to use in a hybridization reaction in a homogenous assay as presently claimed,                         
               Abramson states (column 32, lines 39 through column 33, line 8):                                                    
                       [t]he thermostable DNA polymerases of the present invention which have                                      
                       increased or enhanced 5' to 3' exonuclease activity are particularly useful in the                          
                       homogeneous assay system . . . which generates signal while the target                                      
                       sequence is amplified, thus, minimizing the post-amplification handling of the                              
                       amplified product which is common to other assay systems.  Furthermore, a                                   
                       particularly preferred use of the thermostable DNA polymerase with increased                                
                       5' to 3' exonuclease activity is in a homogeneous assay system which utilizes                               
                       PCR technology.                                                                                             
                       The examiner urges that (Answer, paragraph bridging pages 6-7):                                             
                       [t]he specific teaching cited by Appellant is, in fact, directed towards a                                  
                       homogenous assay in which Abramson states "nucleic acid polymerase having                                   
                       a 5' to 3' nuclease activity under conditions sufficient to permit the 5' to 3'                             
                       nuclease  activity  of  the  polymerase  to  cleave  the  annealed,  labeled                                
                       oligonucleotide and release labeled fragments."  This homogenous assay it                                   

                                                                7                                                                  





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007